Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$19.65
+8.74%
Mkt Cap $2.97B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
Implied Upside
+91.3%
Consensus $37.60 vs current $19.65
NASDAQ·Healthcare·Biotechnology
$19.65
+8.74%
Mkt Cap $2.97B
Buy
5
Hold
1
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
+91.3%
Consensus $37.60 vs current $19.65